Martin Vogelbaum serves as Executive at NephroGenex, Inc., where they oversee executive responsibilities. Since joining the company, Martin Vogelbaum has executed 18 insider transactions totaling $4.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 4, 2024 involved receiving (via award) 301,295 shares valued at $0.
Martin Vogelbaum currently holds 411,007 shares of NephroGenex, Inc. (NRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Vogelbaum has been a net buyer of NRX stock. They have purchased $4.4M and sold $320.3K worth of shares.
Martin Vogelbaum's most recent insider trade was on Jun 4, 2024, when they sold 301,295 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 14, 2022 | CARA | $111.0K | Sale | 10,800 | $10.28 | Discretionary |
| Jun 2, 2022 | CARA | $0 | Award | 23,752 | $N/A | Discretionary |
| Jun 2, 2022 | CARA | $0 | Award | 11,876 | $N/A | Discretionary |
| Jun 7, 2021 | CARA | $112.8K | Sale | 8,640 | $13.05 | Discretionary |
| Jun 3, 2021 | CARA | $0 | Award | 14,400 | $N/A | Discretionary |
| Nov 17, 2020 | CARA | $96.5K | Sale | 6,000 | $16.09 | Discretionary |
| Jun 4, 2020 | CARA | $0 | Award | 14,400 | $N/A | Discretionary |
| Jun 4, 2019 | CARA | $0 | Award | 6,000 | $N/A | Discretionary |
| Jun 4, 2019 | CARA | $0 | Award | 6,000 | $N/A | Discretionary |
| Mar 17, 2016 | CARA | $1.2M | Purchase | 247,727 | $4.93 | Discretionary |
| Mar 16, 2016 | CARA | $727.9K | Purchase | 152,273 | $4.78 | Discretionary |
| Feb 14, 2014 | NRX | $0 | Award | 180,997 | $N/A | Discretionary |
| Feb 14, 2014 | NRX | $0 | Conversion | 203,374 | $N/A | Discretionary |
| Feb 14, 2014 | NRX | $0 | Conversion | 942,455 | $N/A | Discretionary |
| Feb 5, 2014 | CARA | $2.5M | Purchase | 225,818 | $11.00 | Discretionary |
| Feb 5, 2014 | CARA | $0 | Conversion | 2,442,239 | $N/A | Discretionary |